Literature DB >> 9278956

Attenuation of the locomotor activating effects of D-amphetamine, cocaine, and scopolamine by potassium channel modulators.

S Rosenzweig-Lipson1, S Thomas, J E Barrett.   

Abstract

1. Locomotor activating effects of D-amphetamine, cocaine, and scopolamine were determined alone and after pretreatment with K-channel modulators in mice. 2. When administered alone, D-amphetamine (1.0- 30 mg/kg) and cocaine (3.0- 56 mg/kg) produced inverted U-shaped dose-effect curves characteristic of psychomotor stimulant drugs. 3. When administered alone, scopolamine (3.0-56 mg/kg) also produced dose-dependent increases in locomotor activity but these effects plateaued with similar increases in locomotor activity induced by 10-56 mg/kg of scopolamine. 4. Pretreatment with the K-channel blockers 4-aminopyridine (0.3-1.7 mg/kg), quinine (30-100 mg/kg) or apamin (0.3-1.0 mg/kg) attenuated the locomotor increases induced by d-amphetamine, cocaine, and scopolamine. 5. Like the K-channel blockers, pretreatment with the K-channel openers cromakalim (1.0-3.0 mg/kg) and pinacidil (3.0-10 mg/kg) also attenuated the locomotor increases induced by D-amphetamine and scopolamine but did not modify the locomotor activating effects of cocaine. 6. These results demonstrate that K-channel modulation modifies the effects of D-amphetamine, cocaine, and scopolamine. 7. The results also demonstrate that K-channel openers can differentially alter the behavioral effects of cocaine and D-amphetamine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278956     DOI: 10.1016/s0278-5846(97)00085-7

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

1.  Locomotor activating effects of cocaine and scopolamine combinations in rats: isobolographic analysis.

Authors:  Morgane Thomsen
Journal:  Behav Pharmacol       Date:  2014-08       Impact factor: 2.293

2.  4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels.

Authors:  Renato Pirisino; Nicoletta Galeotti; Silvia Livi; Laura Raimondi; Carla Ghelardini
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.

Authors:  M Thiruchelvam; E K Richfield; R B Baggs; A W Tank; D A Cory-Slechta
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

4.  Drug-primed reinstatement of cocaine seeking in mice: increased excitability of medium-sized spiny neurons in the nucleus accumbens.

Authors:  Yao-Ying Ma; Sandy M Henley; Jeff Toll; James D Jentsch; Christopher J Evans; Michael S Levine; Carlos Cepeda
Journal:  ASN Neuro       Date:  2013-10-02       Impact factor: 4.146

5.  Central Administration of Ampelopsin A Isolated from Vitis vinifera Ameliorates Cognitive and Memory Function in a Scopolamine-Induced Dementia Model.

Authors:  Yuni Hong; Yun-Hyeok Choi; Young-Eun Han; Soo-Jin Oh; Ansoo Lee; Bonggi Lee; Rebecca Magnan; Shi Yong Ryu; Chun Whan Choi; Min Soo Kim
Journal:  Antioxidants (Basel)       Date:  2021-05-24

6.  Validation of a nicotine vapor self-administration model in rats with relevance to electronic cigarette use.

Authors:  Lauren C Smith; Marsida Kallupi; Lani Tieu; Kokila Shankar; Abigail Jaquish; Jamie Barr; Yujuan Su; Nathan Velarde; Sharona Sedighim; Lieselot L G Carrette; Mike Klodnicki; Xin Sun; Giordano de Guglielmo; Olivier George
Journal:  Neuropsychopharmacology       Date:  2020-06-16       Impact factor: 7.853

7.  Neuron-specific cilia loss differentially alters locomotor responses to amphetamine in mice.

Authors:  Carlos Ramos; Jonté B Roberts; Kalene R Jasso; Tyler W Ten Eyck; Thomas Everett; Patricia Pozo; Barry Setlow; Jeremy C McIntyre
Journal:  J Neurosci Res       Date:  2020-11-11       Impact factor: 4.164

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.